The novel approach of tirzepatide peptide represents a major advance in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide181224.canariblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56972903